CN Patent

CN106166160A — 用于治疗hcv的组合物

Assigned to Gilead Pharmasset LLC · Expires 2016-11-30 · 9y expired

What this patent protects

本申请涉及一种组合物，所述组合物包含：1)具有如下结构的化合物10，或其药物学上可接受的盐，和2)化合物6，或其药物学上可接受的盐。

USPTO Abstract

本申请涉及一种组合物，所述组合物包含：1)具有如下结构的化合物10，或其药物学上可接受的盐，和2)化合物6，或其药物学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number: CN106166160A
Jurisdiction: CN
Classification: —
Expires: 2016-11-30
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Pharmasset LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.